Academic Commons

Articles

Inhibition of cyclo-oxygenase 2 reduces tumor metastasis and inflammatory signaling during blockade of vascular endothelial growth factor

Kandel, Jessica J.; Johung, Tessa B.; Guarnieri, Paolo; O'Toole, Kathleen Mary; Yamashiro, Darrell J.; Fisher, Jason C.; Gander, Jeffrey W.; Haley, Mary Jo; Hernandez, Sonia L.; Huang, Jianzhong; Chang, Yan-Jung

Vascular endothelial growth factor (VEGF) blockade is an effective therapy for human cancer, yet virtually all neoplasms resume primary tumor growth or metastasize during therapy. Mechanisms of progression have been proposed to include genes that control vascular remodeling and are elicited by hypoperfusion, such as the inducible enzyme cyclooxygenase-2 (COX-2). We have previously shown that COX-2 inhibition by the celecoxib analog SC236 attenuates perivascular stromal cell recruitment and tumor growth. We therefore examined the effect of combined SC236 and VEGF blockade, using the metastasizing orthotopic SKNEP1 model of pediatric cancer. Combined treatment perturbed tumor vessel remodeling and macrophage recruitment, but did not further limit primary tumor growth as compared to VEGF blockade alone. However, combining SC236 and VEGF inhibition significantly reduced the incidence of lung metastasis, suggesting a distinct effect on prometastatic mechanisms. We found that SC236 limited tumor cell viability and migration in vitro, with effects enhanced by hypoxia, but did not change tumor proliferation or matrix metalloproteinase expression in vivo. Gene set expression analysis (GSEA) indicated that the addition of SC236 to VEGF inhibition significantly reduced expression of gene sets linked to macrophage mobilization. Perivascular recruitment of macrophages induced by VEGF blockade was disrupted in tumors treated with combined VEGF- and COX-2-inhibition. Collectively, these findings suggest that during VEGF blockade COX-2 may restrict metastasis by limiting both prometastatic behaviors in individual tumor cells and mobilization of macrophages to the tumor vasculature.

Subjects

Files

  • thumnail for 3130e5eb4beda5c28e304825ddd21c48.zip 3130e5eb4beda5c28e304825ddd21c48.zip binary/octet-stream 4.75 MB Download File
  • thumnail for 2045-824X-3-22-S1.XLS 2045-824X-3-22-S1.XLS binary/octet-stream 7.95 MB Download File

Also Published In

Title
Vascular Cell
DOI
https://doi.org/10.1186/2045-824X-3-22

More About This Work

Academic Units
Surgery
Systems Biology
Pathology and Cell Biology
Publisher
BioMed Central
Published Here
September 8, 2014
Academic Commons provides global access to research and scholarship produced at Columbia University, Barnard College, Teachers College, Union Theological Seminary and Jewish Theological Seminary. Academic Commons is managed by the Columbia University Libraries.